+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Ophthalmology Drugs and Devices Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

  • ID: 3517507
  • Report
  • Region: Global
  • 140 pages
  • Occams Business Research and Consulting
1 of 4
The Global Ophthalmology Drugs And Devices Market Is Expected To Grow At a CAGR Of 7% For the Forecasted Period Of 2015-2021


  • Abbot Laboratories
  • Allergan Inc
  • Carl Zeiss Meditec AG
  • Iridex corporation
  • Nidek Co. Ltd
  • Regeneron
  • MORE
The global ophthalmology drugs market is expected to grow impressively by 2022. The market is driven by various factors which include increase prevalence of eye related disorders such as glaucoma and cataract aging population, regulatory approvals to new drugs and devices, new technologies such as minimally invasive surgical devices, focus on combining drugs and device therapies and increasing economic factors such as rise in disposable income and health expenditure. The market opportunities lie in the growing awareness especially in the emerging and underdeveloped countries, demand for intraocular lenses, phacoemulsification devices and other devices and therapies. However, factors such as expiration of patents, drying pipelines and major slowdowns in economies may hamper the market growth.

The market is segmented on the basis of ophthalmic diagnostic & monitoring equipment market which includes optical coherence tomography scanners market, ultra sound imaging systems, fundus camera market, ophthalmoscopes, retinoscope and other market. The surgical devices include cataract surgery device, intraocular lens market, phacoemulsification devices, glaucoma surgery device market and others. The popular drugs include Lucentis, Eylea, Avastin, Restasis, Lumigan and Ganfort, Xalatan/Xalacom, Pataday and other. The drugs include drugs for glaucoma, retinal disorder, dry eye, allergic conjunctivitis, inflammation and conjunctivitis. The end users include hospitals, eye clinics, diagnostic centres and patients.

The major geographies include North America, Europe, Asia-Pacific and rest of the world. North America is the largest market followed by Europe and Asia pacific. The North American market is driven high awareness, availability of drugs and devices, better regulatory outreach which leads to increased trust in the devices and drugs. Asia Pacific market to have high growth rate driven by strong markets in China and India. Market includes top players such as Abbot Laboratories, Alcon Inc, Ellex Medical lasers ltd, Essilor international S.A., Allergan Inc, Bausch & Lomb Inc, Carl Zeiss Meditec AG, Johnson and Johnson and Hoya Corporation.

1. Abbot Laboratories
2. Alcon Inc
3. Ellex Medical lasers ltd
4. Essilor international S.A.
5. Allergan Inc
6. Bausch & Lomb Inc
7. Carl Zeiss Meditec AG
8. Johnson and Johnson
9. Hoya corporation
10. Pfizer Inc
11. Roche holding AG
12. Santen pharmaceutical co. ltd
13. Staar surgical company
14. Iridex corporation
15. Merc & Co. Inc
16. Nidek Co. Ltd
17. Topcon corporation
18. Novagali Pharma S.A.
19. Novartis AG
20. Nicox
21. Acucela
22. Senju
23. Bayer
24. Valeant
25. Regeneron
26. Akorn
27. Eyemed
28. Visioncare ophthalmic technologies
29. Biotech Visioncare
30. VSP

This Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR up to 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data

Please allow up to 72 hours for delivery.
Note: Product cover images may vary from those shown
2 of 4


  • Abbot Laboratories
  • Allergan Inc
  • Carl Zeiss Meditec AG
  • Iridex corporation
  • Nidek Co. Ltd
  • Regeneron
  • MORE
1. Introduction
1.1. Executive summary
1.2. Estimation methodology
2. Market overview
2.1. Market definition and scope
2.2. Key findings
2.3. Parametric analysis
2.3.1. Prevalence & incidence rate of eye disorders
2.3.2. Hospital and eye clinic across geographies
2.3.3. Increasing cataract surgeries
2.3.4. Healthcare expenditure across geographies
2.3.5. Disposable income of top emerging economies
2.4. Key market insights
2.4.1. Top 3 emerging countries
2.4.2. Top 3 revenue generating segments
2.4.3. Top growing markets and emerging trends
2.4.4. Pipeline analysis SHP616:acute neuromyelitis optica SHP622: friedreich’s ataxia SHP606: dry eye disease Lifitegrast: dry eye disease SHP626: non alcoholic steatohepatitis SHP627: focal segmental glomerulosclerosis Guanfacine: (EU) ADHD MIM-D3: dry eye disease EGP-437: dry eye disease EBI-005: dry eye disease RU-101: dry eye disease OTX-DP: dry eye disease
2.4.5. R&D scenario in ophthalmology market Plasma technology in ophthalmology Cornial topography & cornial analysis Scope of virtual reality technology in eye care
2.5. Competitive intelligence
2.5.1. Market share analysis
2.5.2. Top winning strategies
2.5.3. Case studies: top competitive moves
2.6. Value chain analysis
2.7. Key buying criteria
2.8. Strategic recommendation
2.9. Strategic conclusions
3. Market determinants
3.1. Market drivers
3.1.1. FDA approvals giving rise to adoption of drugs and devices
3.1.2. Global increase in elderly population giving rise to ophthalmology market
3.1.3. Technological advancement
3.1.4. Innovation giving rise to ophthalmology drug and device market
3.1.5. Global increase in prevalence rates of eye diseases
3.1.6. Global increase in adoption of ophthalmology therapies and drugs
3.1.7. Global increase in healthcare expenditure
3.1.8. Global increase in minimally invasive surgeries
3.1.9. High prevalence rates of refractive errors driving the surgeries in ophthalmology market
3.2. Market restraints
3.2.1. Major drugs going off patent is affecting the growth of ophthalmology market
3.2.2. Drying pipelines is a concern for major players
3.3. Market challenges
3.3.1. Risk associated with the ocular diseases
3.3.2. Creating awareness for ophthalmology drug and device market
3.3.3. Global economic slowdown may affect the ophthalmology drug and device market
3.4. Market opportunities
3.4.1. Intraocular lenses, phacoemulsification devices and increasing cataract surgeries to create opportunities in emerging economies
3.4.2. Untapped APAC region has huge scope for ophthalmology drug and device market
3.4.3. Increase in diabetic retinopathies rising the demand for vitreoretinal surgeries
4. Sector Analysis
4.1. Parent market
4.2. Sub-segment market
4.3. Alternative market
5. Top ophthalmic drugs brands
5.1. Lucentis
5.2. Eylea
5.3. Avastin
5.4. Restasis
5.5. Lumigan and Ganfort
5.6. Xalatan/Xalacom
5.7. Travatan/Travatan Z and DuoTrav
5.8. Alphagan/Alphagan P and Combigan
5.9. Vigamox
5.10. Pataday
5.11. Refresh brand products
5.12. Tapros
5.13. Cosopt
6. Market Segmentation
6.1. Global ophthalmology device market
6.1.1. Global ophthalmic diagnostic & monitoring equipment market, 2014-2021,($ millions) Global optical coherence tomography scanners market, 2014-2021,($ millions) Global ophthalmic ultra sound imaging systems market, 2014-2021,($ millions) Global fundus camera market, 2014-2021,($ millions) Global ophthal moscopes, 2014-2021,($ millions) Global retinoscope market , 2014-2021,($ millions) Global pachymeter market, 2014-2021,($ millions) Global wavefront aberrometers market , 2014-2021,($ millions) Global perimeters/visual field analyzer market s, 2014-2021,($ millions) Global autorefractors/phoropter market, 2014-2021,($ millions) Global keratometers, 2014-2021 market,($ millions) Global specular microscope market, 2014-2021,($ millions) Global corneal topoghaphers market, 2014-2021,($ millions) Global tonometers market, 2014-2021,($ millions) Global slit lamps market , 2014-2021,($ millions) Global bio meters market, 2014-2021,($ millions) Global other market, 2014-2021,($ millions)
6.1.2. Global ophthalmology surgery device market , 2014-2021,($ millions) Global cataract surgery device market , 2014-2021,($ millions) Global intraocular lens market, 2014-2021,($ millions) Global phacoemulsification devices market, 2014-2021,($ millions) Global ophthalmic Viscoelastic devices market, 2014-2021,($ millions) Global glaucoma surgery device market, 2014-2021,($ millions) Global stents and implant market, 2014-2021,($ millions) Global glaucoma drainage device market, 2014-2021,($ millions) Global glaucoma system market, 2014-2021,($ millions) Global glaucoma laser market , 2014-2021,($ millions) Global refractive surgery device market, 2014-2021,($ millions) Global excimer laser market, 2014-2021,($ millions) Global emcrokeratome market, 2014-2021,($ millions) Global femtosecond laser market, 2014-2021,($ millions) Global yag laser market, 2014-2021,($ millions) Global vitreoretinal surgery device market , 2014-2021,($ millions) Global photocoagulation laser market, 2014-2021,($ millions) Global illumination device market, 2014-2021,($ millions) Global vitrectomy machine market, 2014-2021,($ millions) Global visioncare market , 2014-2021,($ millions) Global contact lens market , 2014-2021,($ millions) Global spectacles market, 2014-2021,($ millions)
6.2. Global ophthalmology drug market , 2014-2021,($ millions)
6.2.1. Global drug delivery types , 2014-2021,($ millions) Global eye drops market , 2014-2021,($ millions) Global capsules & tablet market, 2014-2021,($ millions) Global eye ointment market, 2014-2021,($ millions) Global gel market , 2014-2021,($ millions) Global eye solution market , 2014-2021,($ millions)
6.2.2. Glaucoma Xalatan (Latanoprost)/Xalacom (Latanoprost and Timolol combination) (Xalabrands) Lumigan franchise [Lumigan (Bimatoprost) + Ganfort (Bimatoprost and Timolol combination)] Tapros/Taflotan (Tafluprost) Saflutan/Zioptan (Tafluprost) Alphagan (Brimonidine)/Combigan (Brimonidine and Timolol combination) Cosopt (Dorzolamide and Timolol combination)/ Trusopt (Dorzolamide) Azarga (Brinzolamide and Timolol combination) Azopt (Brinzolamide)
6.2.3. Global retinal disorder market , 2014-2021,($ millions) Lucentis (Ranibizumab) Visudyne (Verteporfin) Avastin (Bevacizumab) Eylea (Aflibercept)
6.2.4. Dry eye Restasis (Cyclosporine) Hyalein (Sodium hyaluronate) Diquas (Diquafosol sodium)
6.2.5. Allergic conjunctivitis, inflammation and conjunctivitis Patanol/Pataday/Opatanol (Olopatadine) Bepreve (Bepotastine besilate) TobraDex (Tobramycin & Dexamethasone combination) Xibrom/Bromday (Bromfenac) Vigamox (Moxifloxacin) AzaSite (Azithromycin)
6.3. Global ophthalmology drug and device market by therapeutics , 2014-2021,($ millions)
6.3.1. Global diabetic macular edema market, 2014-2021,($ millions)
6.3.2. Global eye cancer market, 2014-2021,($ millions)
6.3.3. Global diabetic retinopathy market, 2014-2021,($ millions)
6.3.4. Global retinal vein occlusion market, 2014-2021,($ millions)
6.3.5. Global age-related macular degeneration market, 2014-2021,($ millions)
6.3.6. Global conjunctivitis market, 2014-2021,($ millions)
6.3.7. Global dry eye market, 2014-2021,($ millions)
6.3.8. Global glaucoma market, 2014-2021,($ millions)
6.3.9. Global keratitis market, 2014-2021,($ millions)
6.3.10. Global lens opacification and intraocular lens market, 2014-2021,($ millions)
6.3.11. Global geographic atrophy market, 2014-2021,($ millions)
6.4. Global ophthalmology drug and device market by end user, 2014-2021,($ millions)
6.4.1. Hospitals
6.4.2. Eye clinics
6.4.3. Diagnostic centers
6.4.4. Patients
7. Competitive Landscape
7.1. Market share
7.2. Strategy – An analysis across tiers
8. Geographical analysis
8.1. North America market, 2014-2021,($ million)
8.1.1. United States (U.S.) market, 2014-2021,($ million)
8.1.2. Canada market, 2014-2021,($ million)
8.2. Europe market, 2014-2021,($ million)
8.2.1. United Kingdom (UK) market, 2014-2021,($ million)
8.2.2. France market, 2014-2021,($ million)
8.2.3. Germany market, 2014-2021,($ million)
8.2.4. Spain market, 2014-2021,($ million)
8.2.5. Italy market, 2014-2021,($ million)
8.2.6. RoE market, 2014-2021,($ million)
8.3. Asia Pacific market, 2014-2021,($ million)
8.3.1. India market, 2014-2021,($ million)
8.3.2. China market, 2014-2021,($ million)
8.3.3. Japan market, 2014-2021,($ million)
8.3.4. Korea market, 2014-2021,($ million)
8.3.5. Australia market, 2014-2021,($ million)
8.3.6. RoAPAC market, 2014-2021,($ million)
8.4. Rest of the world market, 2014-2021,($ million)
8.4.1. Latin America market, 2014-2021,($ million)
8.4.2. MENA market, 2014-2021,($ million)
8.4.3. Africa market, 2014-2021,($ million)
9. Company Profiling: - (Over, SCOT analysis, strategic review)
9.1. Abbot Laboratories
9.2. Alcon Inc
9.3. Ellex Medical lasers ltd
9.4. Essilor international S.A.
9.5. Allergan Inc
9.6. Bausch & Lomb Inc
9.7. Carl Zeiss Meditec AG
9.8. Johnson and Johnson
9.9. Hoya corporation
9.10. Pfizer Inc
9.11. Roche holding AG
9.12. Santen pharmaceutical co. ltd
9.13. Staar surgical company
9.14. Iridex corporation
9.15. Merc & Co. Inc
9.16. Nidek Co. Ltd
9.17. Topcon corporation
9.18. Novagali Pharma S.A.
9.19. Novartis AG
9.20. Nicox
9.21. Acucela
9.22. Senju
9.23. Bayer
9.24. Valeant
9.25. Regeneron
9.26. Akorn
9.27. Eyemed
9.28. Visioncare ophthalmic technologies
9.29. Biotech Visioncare
9.30. VSP
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Abbot Laboratories
Alcon Inc
Ellex Medical lasers ltd
Essilor international S.A.
Allergan Inc
Bausch & Lomb Inc
Carl Zeiss Meditec AG
Johnson and Johnson
Hoya corporation
Pfizer Inc
Roche holding AG
Santen pharmaceutical co. ltd
Staar surgical company
Iridex corporation
Merc & Co. Inc
Nidek Co. Ltd
Topcon corporation
Novagali Pharma S.A.
Novartis AG
Visioncare ophthalmic technologies
Biotech Visioncare
Note: Product cover images may vary from those shown